Today in trading, Knight Therapeutics Inc shares closed at $5.30 after opening the day at $5.41. It traded at a low of $5.29 to a high of $5.48.

The price dipped -2.57% from the previous day's close of $5.44.

During the day across North America, the TSX Composite closed 0.27% at 22167.03, the S&P 500 closed 0.11% at 5254.35, the Dow Jones Industrial Average closed 0.12% at 39807.37 and the Nasdaq Composite closed -0.12% at 16379.46.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

A total of 35,930 shares was traded during the last trading day, with total trades of 201, while having an average volume of 149,695 over the last 5-days.

The TSX overall saw 3,290 price advancers against 1,913 declines and 170 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.75 (January 22,2024) and low as $4.30 (March 29,2023). Moreover, the shares have boosted 21.84% in the last 52 weeks, while they have advanced 2.12% year-to-date.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $550.37 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Currently, Knight Therapeutics Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..